These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 12580400

  • 1. Effect of hydralazine on blood flow, oxygenation, and interstitial fluid pressure in subcutaneous tumors.
    Jarm T, Podobnik B, Sersa G, Miklavcic D.
    Adv Exp Med Biol; 2003; 510():25-9. PubMed ID: 12580400
    [No Abstract] [Full Text] [Related]

  • 2. Oxygenation and blood flow in tumors treated with hydralazine: evaluation with a novel luminescence-based fiber-optic sensor.
    Jarm T, Sersa G, Miklavcic D.
    Technol Health Care; 2002; 10(5):363-80. PubMed ID: 12368557
    [Abstract] [Full Text] [Related]

  • 3. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption.
    Jordan BF, Grégoire V, Demeure RJ, Sonveaux P, Feron O, O'Hara J, Vanhulle VP, Delzenne N, Gallez B.
    Cancer Res; 2002 Jun 15; 62(12):3555-61. PubMed ID: 12068004
    [Abstract] [Full Text] [Related]

  • 4. Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.
    Fenton BM.
    Int J Radiat Oncol Biol Phys; 2001 Mar 01; 49(3):799-808. PubMed ID: 11172963
    [Abstract] [Full Text] [Related]

  • 5. Physiological mechanisms of radiation sensitization by pentoxifylline.
    Lee I, Biaglow JE, Lee J, Cho MJ.
    Anticancer Res; 2000 Mar 01; 20(6B):4605-9. PubMed ID: 11205310
    [Abstract] [Full Text] [Related]

  • 6. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor.
    Constantinidis I, Gamcsik MP.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):143-9. PubMed ID: 7642412
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors.
    Kalmus J, Okunieff P, Vaupel P.
    Cancer Res; 1990 Jan 01; 50(1):15-9. PubMed ID: 2293549
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation.
    Zlotecki RA, Baxter LT, Boucher Y, Jain RK.
    Microvasc Res; 1995 Nov 01; 50(3):429-43. PubMed ID: 8583955
    [Abstract] [Full Text] [Related]

  • 9. The energy metabolism of RIF-1 tumours following hydralazine.
    Bhujwalla ZM, Tozer GM, Field SB, Maxwell RJ, Griffiths JR.
    Radiother Oncol; 1990 Nov 01; 19(3):281-91. PubMed ID: 2281156
    [Abstract] [Full Text] [Related]

  • 10. Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.
    Zlotecki RA, Boucher Y, Lee I, Baxter LT, Jain RK.
    Cancer Res; 1993 Jun 01; 53(11):2466-8. PubMed ID: 8495405
    [Abstract] [Full Text] [Related]

  • 11. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline.
    Lee I, Boucher Y, Demhartner TJ, Jain RK.
    Br J Cancer; 1994 Mar 01; 69(3):492-6. PubMed ID: 8123479
    [Abstract] [Full Text] [Related]

  • 12. Differences in vascular response between primary and transplanted tumours.
    Field SB, Needham S, Burney IA, Maxwell RJ, Coggle JE, Griffiths JR.
    Br J Cancer; 1991 May 01; 63(5):723-6. PubMed ID: 1645562
    [Abstract] [Full Text] [Related]

  • 13. Effect of hydralazine on interstitial fluid pressure in experimental tumours and in normal tissue.
    Podobnik B, Sersa G, Miklavcic D.
    In Vivo; 2001 May 01; 15(5):417-24. PubMed ID: 11695240
    [Abstract] [Full Text] [Related]

  • 14. Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions.
    Crokart N, Jordan BF, Baudelet C, Ansiaux R, Sonveaux P, Grégoire V, Beghein N, DeWever J, Bouzin C, Feron O, Gallez B.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):901-10. PubMed ID: 16199320
    [Abstract] [Full Text] [Related]

  • 15. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
    Horsman MR, Christensen KL, Overgaard J.
    Int J Hyperthermia; 1989 Nov 01; 5(2):123-36. PubMed ID: 2926180
    [Abstract] [Full Text] [Related]

  • 16. Basic fibroblast growth factor infusion increases tumour vascularity, blood flow and chemotherapy uptake.
    Davies MM, Burke D, Carnochan P, Glover C, Kaur S, Allen-Mersh TG.
    Acta Oncol; 2002 Nov 01; 41(1):84-90. PubMed ID: 11990524
    [Abstract] [Full Text] [Related]

  • 17. Blood flow modification in the SCCVII tumor: effects of 5-hydroxytryptamine, hydralazine, and propranolol.
    Peters CE, Chaplin DJ.
    Int J Radiat Oncol Biol Phys; 1992 Nov 01; 22(3):463-5. PubMed ID: 1735679
    [Abstract] [Full Text] [Related]

  • 18. Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice.
    Lin JC, Song CW.
    Radiat Res; 1990 Nov 01; 124(2):171-7. PubMed ID: 2247597
    [Abstract] [Full Text] [Related]

  • 19. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.
    Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK.
    Cancer Res; 1992 Dec 01; 52(23):6553-60. PubMed ID: 1384965
    [Abstract] [Full Text] [Related]

  • 20. EPR oximetry of tumors in vivo in cancer therapy.
    Sentjurc M, Cemazar M, Sersa G.
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May 01; 60(6):1379-85. PubMed ID: 15134738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.